|
|
Volumn 13, Issue 9, 2000, Pages 560-566
|
|
Defining the role of COX-2 inhibitors in inflammatory and other diseases
a
a
BWS
(United Kingdom)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 AMINOPHENAZONE;
6 (2,4 DIFLUOROPHENYLTHIO) 5 METHANESULFONAMIDO 1 INDANONE;
ACETYLSALICYLIC ACID;
CELECOXIB;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
DICLOFENAC;
DIFLUNISAL;
ETODOLAC;
FENOPROFEN;
FLURBIPROFEN;
IBUPROFEN;
INDOMETACIN;
KETOPROFEN;
KETOROLAC;
MECLOFENAMIC ACID;
MELOXICAM;
N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE;
NAPROXEN;
NIFLUMIC ACID;
NIMESULIDE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PIROXICAM;
ROFECOXIB;
SALICYLATE SODIUM;
SULINDAC SULFIDE;
SUPROFEN;
TOLMETIN;
ZOMEPIRAC;
ALZHEIMER DISEASE;
CANCER;
CARDIOVASCULAR SYSTEM;
CONFERENCE PAPER;
DISEASE ASSOCIATION;
DRUG DETERMINATION;
DRUG EFFECT;
DRUG SAFETY;
DRUG SELECTIVITY;
GASTROINTESTINAL TOXICITY;
HUMAN;
INFLAMMATION;
KIDNEY;
|
|
EID: 0034494622
PISSN: 02140934
EISSN: None
Source Type: Journal
DOI: 10.1358/dnp.2000.13.9.660938 Document Type: Conference Paper |
|
Times cited : (13)
|
|
References (4)
|
